A Transatlantic healthcare technology group
Through our US-UK network, we source, develop and manage early/mid-stage healthcare technology companies focused on Diagnostics, Digital health and Therapeutics.
We are focused on providing management support for our investments which can involve senior team members at NetScientific taking leadership roles in portfolio companies, in the early stages of investment, to build out dedicated management teams.
Three portfolio companies: Glycotest, PDS Biotech and ProAxsis
£2.5mln of cash in the bank
PDS Biotech due to carry out phase II trial of lead drug this year
Director Interviews
Investor Update: ANGLE reports positive data from Parsortix FDA clinical study
Director Interviews
'Pivotal' moment for NetScientific's Glycotest Inc with $10mln financing
